Results 21 to 30 of about 45,109 (224)
Facile Synthesis of Propranolol and Novel Derivatives
Propranolol is one of the first medications of the beta-blocker used for antihypertensive drugs. This study reports the facile route for the synthesis of propranolol and its novel derivatives.
Vy Anh Tran +9 more
doaj +1 more source
The development of bacterial resistance is an increasing global concern that requires discovering new antibacterial agents and strategies. Bacterial quorum sensing (QS) systems play important roles in controlling bacterial virulence, and their targeting ...
Hadil Faris Alotaibi +7 more
doaj +1 more source
BackgroundBeta-blockers can reduce recurrence, metastasis, and mortality in various cancers. In this study, we investigated the effect of propranolol, a non-selective beta-blocker on overall survival (OS) in unresectable/metastatic hepatocellular ...
Ping-Ying Chang +7 more
doaj +1 more source
Osteosarcoma is still associated with limited response to standard-of-care therapy and alarmingly elevated mortality rates, especially in low- and middle-income countries.
Luisina M. Solernó +7 more
doaj +1 more source
Background: Recent explorative studies suggest that propranolol reduces retinopathy of prematurity (ROP) progression, but the short-term effects of propranolol treatment at 1 year of corrected age have not been extensively evaluated.Methods: A multi ...
Luca Filippi +15 more
doaj +1 more source
Efficient Propranolol Delivery Enabled by Manganese-Based Bioactive Metal-Organic Frameworks With High Loading Capacity. [PDF]
A green and efficient method has been developed for propranolol delivery utilizing manganese‐based bioactive MOFs as biocompatible drug carriers. Mn‐based bioactive MOFs with a high aspect ratio are synthesized and characterized for size, morphology, stability, elemental composition, crystallinity, functionality, charge character, and biocompatibility [
Borhanipasvisheh H +2 more
europepmc +2 more sources
BackgroundPropranolol for infantile hemangiomas (IHs) is effective and relatively safe. However, propranolol has different formulations and there is no consensus on the optimal formulation for IHs.
Wenting Chen +8 more
doaj +1 more source
Propranolol in hypertension [PDF]
Summary Twenty-four hypertensive patients, eleven of whom had angina pectoris as well, have been treated with propranolol in doses up to 400 mg daily. The thirteen patients without angina received methyldopa 2 g daily in addition to propranolol. A significant reduction of systolic and diastolic blood pressure was found in both groups.
S N, Tewari, R H, Grant
openaire +2 more sources
Involvement of propranolol in suicides: cross-sectional study using coroner-reported data
Background Propranolol is a beta-blocker medication indicated mostly for heart rhythm conditions and for physical symptoms of anxiety. Prescriptions for propranolol in the UK have increased since 2008.
Hayley C. Gorton +4 more
doaj +1 more source
Propranolol: A 50-year historical perspective
Propranolol is a beta-adrenergic receptor antagonist that was developed by the British scientist Sir James Black primarily for the treatment of angina pectoris, more than 50 years ago.
A V Srinivasan
doaj +1 more source

